Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Mar 23;49(6):1946-52.
doi: 10.1021/jm0510326.

Development of cyclic gamma-MSH analogues with selective hMC3R agonist and hMC3R/hMC5R antagonist activities

Alexander V Mayorov  1 , Minying Cai, Kevin B Chandler, Ravil R Petrov, April R Van Scoy, Zerui Yu, Dustin K Tanaka, Dev Trivedi, Victor J Hruby
Affiliations

Development of cyclic gamma-MSH analogues with selective hMC3R agonist and hMC3R/hMC5R antagonist activities

Alexander V Mayorov et al. J Med Chem. .

Abstract

A series of cyclic lactam analogues of gamma-MSH (H-Tyr1-Val2-Met3-Gly4-His5-Phe6-Arg7-Trp8-Asp9-Arg10-Phe11-Gly12-OH) with a bulky hydrophobic residue in the direct proximity to the pharmacophore (Xaa-D-Phe/D-Nal(2')-Arg-Trp) were designed and synthesized by solid-phase methods. A variety of amino acids with a broad range of hydrophobic/hydrophilic properties was introduced in position 5 to further explore their complementary role in receptor selectivity. Biological evaluation of these peptides revealed several analogues with potent hMC3R agonist and hMC3R/hMC5R antagonist activities, and good receptor selectivity. Analogue 4, c[Nle-Arg-D-Phe-Arg-Trp-Glu]-NH2, was found to be a very potent and selective hMC3R agonist (EC50=1.2 nM, 112% act). In addition, analogue 13, c[Nle-Val-D-Nal(2')-Arg-Trp-Glu]-NH2, was identified as an hMC3R/hMC5R antagonist with the best selectivity against the hMC4R in this series (pA2(hMC3R)=8.4; pA2(hMC5R)=8.7). These results indicate the significance of steric factors in melanocortin receptor selectivity and suggest that introduction of bulky residues in the direct proximity to the melanocortin pharmacophore is an effective approach to design of novel hMC3R and hMC5R selective ligands.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Design of the novel γ-MSH-derived cyclic lactam scaffold.
Figure 2
Figure 2
Stereoview of the superimposed global minimum of analogue 1, c[Nle-His-d-Phe-Arg-Trp-Glu]-NH2, obtained by MCMM/LMCS (Monte Carlo multiple minima-low-frequency mode)-OPLS-AA simulation with the NMR structure of nonselective superagonist MT-II, Ac-Nle-c[Asp-His-d-Phe-Arg-Trp-Lys]-NH2 (rmsd = 0.21 Å). Hydrogens are omitted for clarity.
Figure 3
Figure 3
Stereoview of the superimposed global minimum of analogue 9, c[Nle-His-d-Nal(2′)-Arg-Trp-Glu]-NH2, obtained by MCMM/LMCS (Monte Carlo multiple minima-low-frequency mode)-OPLS-AA simulation with the NMR structure of hMC3R/hMC4R antagonist SHU9119, Ac-Nle-c[Asp-His-d-Nal(2′)-Arg-Trp-Lys]-NH2 (rmsd = 0.44 Å). Hydrogens are omitted for clarity.
Figure 4
Figure 4
Influence of steric interference from Nle,4 placed in close proximity to the pharmacophore, on the melanocortin receptor selectivity.
Figure 5
Figure 5
Stereoview of the global minimum of analogue 7, c[Nle-Asp-d-Phe-Arg-Trp-Glu]-NH2, obtained by MCMM/LMCS (Monte Carlo multiple minima-low-frequency mode)-OPLS-AA simulation. Hydrogens are omitted for clarity.
See this image and copyright information in PMC

References

    1. Pritchard LE, Turnbull AV, White A. Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signaling and obesity. J Endocrinol. 2002;172:411–421. - PubMed
    1. Hruby VJ, Wilkes BC, Hadley ME, Al-Obeidi F, Sawyer TK, Staples DJ, de Vaux AE, Dym O, Castrucci AMF, Hintz MF, Riehem JP, Rao KR. α-Melanotropin: The minimal active sequence in the frog skin bioassay. J Med Chem. 1987;30:2126–2130. - PubMed
    1. Castrucci A-Mde L, Hadley ME, Sawyer TK, Wilkes BC, Al-Obeidi F, Staples DJ, de Vaux AE, Dym O, Hintz MF, Riehm JP, Rao RR, Hruby VJ. α-Melanotropin: The minimal active sequence in the lizard skin bioassay. Gen Comput Endocrinol. 1989;73:157–163. - PubMed
    1. Hadley, M. E.; Castrucci, A.-M. de L. Melanotropin Mechanisms of Action: Melanosome Movements. In The Melanotropic Peptides. Mechanisms of Action and Biomedical Applications; Hadley, M. E., Ed.; CRC Press: Boca Raton, FL, 1988; Vol. III, pp 15–25.
    1. Cone, R. D., Ed. The melanocortin system. Ann NY Acad Sci2003, 994, pp 1–387.

Publication types

MeSH terms

LinkOut - more resources